作为碳氧酸酶和酸酶抑制剂的阿纳贝诺佩的结构-活性关系
Megan L Quandt1, Judy Westrick1, Jeremy J Kodanko1
1Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, Michigan 48202, United States.
ACS chemical biology
|January 21, 2026
概括
亚纳贝诺,蓝藻细菌的,抑制关键的酶,如碳氧和酸酶. 本综述分析了它们的结构-活性关系,以寻求潜在的治疗开发.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 环境科学 环境科学
背景情况:
- 烯是来自蓝藻细菌的循环,具有显著的酶抑制特性.
- 它们向关键的酶,包括碳氧酸酶A/B和氨酸/氨酸酸酶PP1/PP2A.
- 它们的宏循环环和外循环氨基酸的影响力和选择性的结构变化.
研究的目的:
- 编制和分析已公布的自然和合成阿纳贝诺皮因的IC50值.
- 为了确定结构-活性关系 (SAR),驱动针对特定酶标的抑制活性.
- 为了突出趋势,测试标准化中的差距,以及对anabaenopeptins的结构验证.
主要方法:
- 系统性审查关于anabaenopeptins的已发表文献.
- 基于酶标的IC50数据的编制和组织.
- 结构动图的比较分析及其与抑制活性的相关性.
主要成果:
- 亚纳巴诺胺对碳氧酶和酸酶表现出强大的抑制作用.
- 特定的结构特征经常与高抑制活性有关.
- 在SAR中识别的趋势为anabaenopeptin疗效提供了洞察力.
结论:
- 亚纳巴诺丁作为机械探针和治疗支架表现有前途.
- 需要进一步的研究来解决测试标准化和结构验证的问题.
- 了解SAR对于开发anabaenopeptins作为环境或治疗剂至关重要.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Protein Kinases and Phosphatases
15.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Local Anesthetics: Chemistry and Structure-Activity Relationship
6.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
934
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
934


